Fresenius Medical Care AG & Co. KGaA (FME.DE) XETRA

Currency In EUR

AD

Fresenius Medical Care AG & Co. KGaA

Address

Else-KrOener Strasse 1

Bad Homburg, 61352

Germany

Phone

49 6172 608 2522

Sector

Healthcare

Industry

Medical - Care Facilities

Employees

112035

First IPO Date

July 22, 1998

Key Executives

NameTitlePayYear Born
Joseph E. Turk Jr.Chief Executive Officer of Care Enablement & Member of Management Board3.16M1968
Craig Cordola FACHEChief Executive Officer of Care Delivery & Member of Management Board3.25M1972
Helen GizaChair of Management Board & Chief Executive Officer3.76M1968
Jorg HaringMember of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director1.65M1970
Martin FischerChief Financial Officer & Member of the Management Board2.18M1978
Charles Hugh-JonesGlobal Chief Medical Officer & Member of Management Board2.65M1970
Dominik HegerExecutive Vice President and Head of Investor Relations, Strategic Development & Communications0N/A
Gail-Suzanne BrownSenior Vice President of Research & Development0N/A
Glenn SlaterSenior Vice President of Manufacturing and Supply Chain Operations0N/A
Joachim WeithSenior Vice President of Corporate Communications & Governmental Affairs0N/A
AD

Description

Fresenius Medical Care AG & Co. KGaA operates as a premier international provider of comprehensive dialysis services and related care, with a significant presence in Germany, North America, and numerous other countries. The company delivers essential dialysis treatments, laboratory analyses, and diagnostic services through its extensive network of outpatient dialysis clinics. Complementing its clinical offerings, Fresenius provides necessary materials, patient training, ongoing clinical monitoring, follow-up support, and arranges for the delivery of supplies directly to patients' residences. In the United States, Fresenius extends its services to hospitals, offering contract dialysis care for inpatients suffering from end-stage renal disease (ESRD) and those experiencing acute kidney failure. Beyond services, the company is a key player in the development, manufacturing, and global distribution of a broad spectrum of dialysis products. This portfolio includes items such as polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, specialized solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, Fresenius produces non-dialysis products, including those for acute cardiopulmonary conditions and apheresis. The company further enhances its offerings by developing, acquiring, and in-licensing renal pharmaceuticals, ensuring these medications and other vital supplies reach patients at home or in dialysis clinics. It also provides an array of specialized medical services, covering vascular, cardiovascular, and endovascular care, operating vascular care ambulatory surgery centers, and delivering physician nephrology and cardiology services. Fresenius Medical Care distributes its extensive product range to dialysis clinics, hospitals, and specialized treatment centers via multiple avenues, including direct sales, dedicated local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, the company managed an impressive 4,171 outpatient dialysis clinics across approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was established in 1996 and is headquartered in Bad Homburg, Germany.

AD